Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
After 72 weeks, Zepbound outperformed Wegovy in both primary endpoints and all five secondary endpoints in a study involving adults with obesity or overweight, at least one weight-related health issue, and no diabetes
Pulmonary embolism is a blood clot that restricts blood flow to the lungs
The best time of day to inject can also affect how side effects overlap with your daily routine
Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H (2016) Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients with type 2 diabetes: the study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A)
Below are some of the most commonly used GLP-1 medications: Dulaglutide (Trulicity) Exenatide (Bydureon BCise) Liraglutide (Saxenda, Victoza) Semaglutide (Ozempic, Rybelsus, Wegovy) Tirzepatide (Mounjaro, Zepbound) These medications differ in their dosing schedules, mechanisms of administration, and specific indications, but all work the same to improve blood sugar levels and support improved long-term health outcomes
Many patients do, under physician guidance
